Iovance Biotherapeutics (IOVA) News Today $2.38 +0.17 (+7.69%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$2.40 +0.02 (+0.63%) As of 05:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is Iovance Biotherapeutics Up Today?Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares have declined amid growing legal and commercial headwinds. Investors are reacting to an influx of securities class action filings and a prominent analyst downgrade, partially offset by upcoming investor presentations. Iovance to present at an upcoming conference, offering management an opportunity to reassess clinical progress and engage with analysts and potential partners. Reported increase in short interest for June, though current figures show negligible shares shorted and a days-to-cover ratio of 0.0. Numerous securities class action lawsuits filed against Iovance and its executives, raising concerns over potential financial liabilities and management distraction. UBS downgraded Iovance from Buy to Neutral and cut its price target from $17 to $2, citing challenges in the commercial rollout of its cell therapy Amtagvi. Posted 9h agoAI Generated. May Contain Errors. IOVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVAJune 10 at 10:33 PM | globenewswire.comIovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJune 10 at 1:46 PM | prnewswire.comIovance Biotherapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before July 14, 2025 to Discuss Your Rights – IOVAJune 10 at 1:08 PM | globenewswire.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance BiotherapeuticsJune 10 at 10:12 AM | prnewswire.comIOVA LEGAL NOTICE: Lose Money when Iovance Biotherapeutics, Inc. Stock Plummeted 44%? Contact BFA Law by the July 14 Court Deadline (NASDAQ:IOVA)June 10 at 8:47 AM | globenewswire.comIovance Biotherapeutics to Present at Upcoming ConferenceJune 10 at 8:45 AM | globenewswire.comShareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreJune 10 at 5:45 AM | prnewswire.comThe Gross Law Firm Notifies Iovance Biotherapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – IOVAJune 9 at 1:36 PM | globenewswire.comROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVAJune 9 at 1:23 PM | globenewswire.comIovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Up - Still a Buy?Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Up - Here's What HappenedJune 9 at 12:20 PM | marketbeat.comIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. ...June 9 at 11:32 AM | gurufocus.comIOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. ...June 9 at 11:32 AM | gurufocus.comIOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELVJune 9 at 10:23 AM | prnewswire.comIovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens BermanJune 9 at 9:08 AM | globenewswire.comShareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) should contact The Gross Law Firm about pending Class Action - IOVAJune 9 at 5:45 AM | prnewswire.comIOVA INVESTOR NEWS: Iovance Biotherapeutics, Inc. ...June 8 at 9:08 AM | gurufocus.comIOVA INVESTOR NEWS: Iovance Biotherapeutics, Inc. has been Sued for Securities Fraud – Contact BFA Law before July 14 Deadline (NASDAQ:IOVA)June 8 at 8:18 AM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVAJune 7, 2025 | prnewswire.comGoldman Sachs Sticks to Its Buy Rating for Iovance Biotherapeutics (IOVA)June 7, 2025 | theglobeandmail.comIOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVAJune 6, 2025 | prnewswire.comIovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens BermanJune 6, 2025 | globenewswire.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)June 6, 2025 | globenewswire.comIovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJune 6, 2025 | prnewswire.comIovance Biotherapeutics (NASDAQ:IOVA) Trading 7.5% Higher - Time to Buy?Iovance Biotherapeutics (NASDAQ:IOVA) Trading 7.5% Higher - Here's What HappenedJune 6, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVAJune 6, 2025 | globenewswire.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance BiotherapeuticsJune 6, 2025 | globenewswire.comIOVA INVESTOR NOTICE: Iovance Biotherapeutics, Inc. Investors with Losses are Notified of the Ongoing Securities Fraud Class Action and July 14 Deadline – BFA Law (NASDAQ:IOVA)June 6, 2025 | globenewswire.comInvestors in Iovance Biotherapeutics, Inc. Should Contact Levi & Korsinsky Before July 14, 2025 to Discuss Your Rights - IOVAJune 6, 2025 | prnewswire.comIOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJune 5, 2025 | globenewswire.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVAJune 5, 2025 | globenewswire.comContact Levi & Korsinsky by July 14, 2025 Deadline to Join Class Action Against Iovance Biotherapeutics, Inc. (IOVA)June 5, 2025 | globenewswire.comDeadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitJune 5, 2025 | globenewswire.comThe Gross Law Firm Notifies Shareholders of Iovance Biotherapeutics, Inc.(IOVA) of a Class Action Lawsuit and an Upcoming DeadlineJune 5, 2025 | prnewswire.comIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Sold by Ameriprise Financial Inc.Ameriprise Financial Inc. trimmed its position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA - Free Report) by 88.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 62,548 shares of the biotechnology company's stock after selling 494,98June 5, 2025 | marketbeat.comIOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVAJune 4, 2025 | globenewswire.comIovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens BermanJune 4, 2025 | globenewswire.comShareholders of Iovance Biotherapeutics, Inc. Should Contact The Gross Law Firm Before July 14, 2025 to Discuss Your Rights – IOVAJune 4, 2025 | globenewswire.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance BiotherapeuticsJune 4, 2025 | prnewswire.comIOVA LAWSUIT NOTICE: Lose Money on Iovance Biotherapeutics, Inc.? BFA Law Alerts Investors that the Class Action Could Allow Investors to Recover Losses (NASDAQ:IOVA)June 4, 2025 | globenewswire.comAnalysts Set Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Target Price at $13.30June 4, 2025 | americanbankingnews.comIOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVAJune 3, 2025 | globenewswire.comIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud LawsuitJune 2, 2025 | prnewswire.comIOVA Stock News: Stockholders with Significant Losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the Class Action Lawsuit Against Iovance Biotherapeutics, Inc.June 2, 2025 | prnewswire.comIovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens BermanJune 2, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVAJune 2, 2025 | globenewswire.comScott+Scott Attorneys at Law LLP Continues to Remind Investors There is a Securities Class Action Filed Against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)June 2, 2025 | globenewswire.comIOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELVJune 2, 2025 | prnewswire.comThe Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced MelanomaJune 2, 2025 | globenewswire.comIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmJune 2, 2025 | prnewswire.comIOVA STOCK: Suffer Losses on Iovance Biotherapeutics, Inc.? BFA Law Notifies Investors of Imminent July 14 Securities Class Action Deadline (NASDAQ:IOVA)June 2, 2025 | globenewswire.com Get Iovance Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address IOVA Media Mentions By Week IOVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IOVA News Sentiment▼0.061.01▲Average Medical News Sentiment IOVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IOVA Articles This Week▼4010▲IOVA Articles Average Week Get Iovance Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MorphoSys News Today Immunovant News Today HUTCHMED News Today Organon & Co. News Today Ascentage Pharma Group International News Today Apellis Pharmaceuticals News Today Xenon Pharmaceuticals News Today Amneal Pharmaceuticals News Today Mirum Pharmaceuticals News Today Arrowhead Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IOVA) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IOVA Stock Free IOVA Stock Alerts